Total Payments
$451.98
2024 Payments
$212.20
Companies
8
Transactions
16
Medicare Patients
5,859
Medicare Billing
$595,451
Payment Breakdown by Category
Food & Beverage$426.08 (94.3%)
Education$25.90 (5.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $426.08 | 14 | 94.3% |
| Education | $25.90 | 2 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tempus AI, Inc | $141.48 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $79.74 | 3 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $79.36 | 1 | $0 (2018) |
| Genentech, Inc. | $49.54 | 2 | $0 (2018) |
| Janssen Biotech, Inc. | $34.18 | 2 | $0 (2024) |
| Medtronic, Inc. | $29.68 | 1 | $0 (2023) |
| Acrotech Biopharma LLC | $25.90 | 2 | $0 (2022) |
| Gilead Sciences, Inc. | $12.10 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $212.20 | 7 | Tempus AI, Inc ($141.48) |
| 2023 | $54.22 | 2 | Medtronic, Inc. ($29.68) |
| 2022 | $44.56 | 3 | Acrotech Biopharma LLC ($25.90) |
| 2018 | $141.00 | 4 | Janssen Scientific Affairs, LLC ($79.36) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $113.90 | General |
| 08/28/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Oncology | ||||||
| 06/04/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $4.59 | General |
| 05/03/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $18.91 | General |
| 04/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Oncology | ||||||
| 02/13/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $4.08 | General |
| 09/27/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Oncology | ||||||
| 08/31/2023 | Medtronic, Inc. | OSTEOCOOL RF ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 07/19/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Oncology | ||||||
| 03/22/2022 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $13.93 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2022 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $11.97 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.10 | General |
| 05/17/2018 | Janssen Scientific Affairs, LLC | Erleada (Drug) | Food and Beverage | In-kind items and services | $79.36 | General |
| Category: Oncology | ||||||
| 01/27/2018 | Genentech, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: BioOncology | ||||||
| 01/14/2018 | Genentech, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,114 | 3,516 | $322,375 | $140,256 |
| 2022 | 11 | 1,175 | 3,831 | $372,412 | $164,750 |
| 2021 | 18 | 1,659 | 4,028 | $348,885 | $151,785 |
| 2020 | 22 | 1,911 | 5,132 | $385,517 | $138,659 |
Total Patients
5,859
Total Services
16,507
Medicare Billing
$595,451
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 626 | $110,138 | $55,042 | 50.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 115 | 319 | $78,132 | $40,202 | 51.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 231 | 887 | $12,036 | $7,451 | 61.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 165 | 666 | $35,298 | $6,893 | 19.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 50 | $16,650 | $6,669 | 40.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 39 | 71 | $14,484 | $6,490 | 44.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 38 | 38 | $12,336 | $5,537 | 44.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 169 | 718 | $28,002 | $5,464 | 19.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 64 | $8,576 | $3,892 | 45.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 36 | $4,446 | $2,037 | 45.8% |
| 36591 | Collection of blood sample from implanted device | Office | 2023 | 11 | 25 | $1,525 | $446.40 | 29.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 12 | 16 | $752.00 | $132.64 | 17.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 131 | 557 | $126,996 | $71,984 | 56.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 215 | 418 | $68,134 | $34,878 | 51.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 50 | 165 | $33,660 | $12,886 | 38.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 57 | 72 | $23,976 | $10,910 | 45.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 52 | 155 | $20,770 | $8,455 | 40.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 56 | 56 | $17,528 | $8,085 | 46.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 163 | 660 | $34,980 | $6,884 | 19.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 166 | 762 | $29,718 | $5,845 | 19.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 235 | 923 | $11,076 | $2,734 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 39 | $4,446 | $1,889 | 42.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 19 | 24 | $1,128 | $200.45 | 17.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 235 | 527 | $85,249 | $46,733 | 54.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 121 | 331 | $73,908 | $44,457 | 60.2% |
About Dr. Mohan Tummala, MD
Dr. Mohan Tummala, MD is a Hematology & Oncology healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174667109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohan Tummala, MD has received a total of $451.98 in payments from pharmaceutical and medical device companies, with $212.20 received in 2024. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($426.08).
As a Medicare-enrolled provider, Tummala has provided services to 5,859 Medicare beneficiaries, totaling 16,507 services with total Medicare billing of $595,451. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Springfield, MO
- Active Since 02/15/2007
- Last Updated 10/03/2014
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1174667109
Products in Payments
- Erleada (Drug) $79.36
- KISQALI (Drug) $55.20
- TECENTRIQ (Biological) $49.54
- OSTEOCOOL RF ABLATION SYSTEM (Device) $29.68
- BELEODAQ (Drug) $25.90
- PLUVICTO (Drug) $24.54
- DARZALEX (Biological) $18.66
- TECVAYLI (Biological) $15.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Springfield
Dr. Joshua Strauss, M.d, M.D
Hematology & Oncology — Payments: $546,737
Hematology & Oncology $546,737
Dr. Preet Singh, Md, MD
Hematology & Oncology — Payments: $460,137
Hematology & Oncology $460,137
Dr. Ashish Shah, D.o, D.O
Hematology & Oncology — Payments: $323,857
Hematology & Oncology $323,857
Syed Ali, Md, MD
Hematology & Oncology — Payments: $237,324
Hematology & Oncology $237,324
Dr. Maithili Rao, M.d, M.D
Hematology & Oncology — Payments: $102,596
Hematology & Oncology $102,596
Ashish Khot, Md, MD
Hematology & Oncology — Payments: $79,812
Hematology & Oncology $79,812